Novo Nordisk partners with OpenAI to speed drug discovery
The race to develop the next generation of medicines just got faster. At least, that is the bet Novo[……] Read…
Danish drugmaker Novo Nordisk taps OpenAI in drug R&D
The deal builds on staff access to a custom version of ChatGPT to help scientists identify drug targ[……] Read More
Hims & Hers shifts business model after Novo deal
Hims & Hers (HIMS) has taken a beating, with the stock down roughly 70% from its $70 peak and no[……]…